GABRIELLA BASDEKIS: Open Payments
NPI 1215709878 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,154 in 86 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $1,275 · 2025 $2,154
Food & beverage: $2,154
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $622 |
| Janssen Biotech, Inc. | 11 | $405 |
| Madrigal Pharmaceuticals | 4 | $207 |
| Phathom Pharmaceuticals, Inc. | 6 | $151 |
| Boston Scientific Corporation | 1 | $121 |
| Ardelyx, Inc. | 5 | $81 |
| Intercept Pharmaceuticals, Inc. | 4 | $77 |
| QOL Medical, LLC | 5 | $76 |
| Lilly USA, LLC | 3 | $57 |
| Gilead Sciences, Inc. | 2 | $52 |
Products named: TREMFYA, RINVOQ, REZDIFFRA, VOQUEZNA, MAVYRET, SKYRIZI, Axonics, IBSRELA.
Industry payments across NC — which companies pay providers there.
